Literature DB >> 28400282

MicroRNA-153-3p suppress cell proliferation and invasion by targeting SNAI1 in melanoma.

Hai Feng Zeng1, Shen Yan2, Su Fan Wu1.   

Abstract

Malignant melanoma is one of the most common malignancies of the skin cancer and increasing evidences revealed that microRNAs (miRNAs) exert significant effects in melanoma. In the present study, the underlying function of microRNA-153-3p (miR-153-3p) in melanoma was investigated from different levels, including cell level, protein level and gene level. Our results showed that expression of miR-153-3p was lower in melanoma tissues and melanoma cells compared with the para-tumor tissue and normal melanocytes. The overexpression of miR-153-3p inhibited the cell proliferation and invasion, at the same time promoted cell apoptosis. Moreover, we identified that snail family transcriptional repressor 1 (SNAI1) is the direct target of miR-153-3p, and there is a negative correlation between miR-153-3p level and SNAI1 expression. In summary, we presented the evidences that miR-153-3p may act as a tumor suppressor by down-regulating the expression of SNAI1 in melanoma and miR-153-3p might be a potential biomarker in the diagnosis and treatment of malignant melanoma.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Melanoma; SNAI1; miR-153-3p; microRNA-153-3p

Mesh:

Substances:

Year:  2017        PMID: 28400282     DOI: 10.1016/j.bbrc.2017.04.032

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  Unique microRNA Signals in Plasma Exosomes from Pregnancies Complicated by Preeclampsia.

Authors:  Hui Li; Yingshi Ouyang; Elena Sadovsky; W Tony Parks; Tianjiao Chu; Yoel Sadovsky
Journal:  Hypertension       Date:  2020-01-27       Impact factor: 10.190

Review 2.  Circular RNAs: epigenetic regulators in cancerous and noncancerous skin diseases.

Authors:  Abbas Abi; Najmeh Farahani; Ghader Molavi; Seyed Mohammad Gheibi Hayat
Journal:  Cancer Gene Ther       Date:  2019-09-03       Impact factor: 5.987

Review 3.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

4.  MicroRNA-610 inhibits tumor growth of melanoma by targeting LRP6.

Authors:  Guangjing Zhang; Dongfang Ai; Xiufang Yang; Shanshan Ji; Zhengxiang Wang; Shijun Feng
Journal:  Oncotarget       Date:  2017-10-26

5.  Hypoxia induces miR-153 through the IRE1α-XBP1 pathway to fine tune the HIF1α/VEGFA axis in breast cancer angiogenesis.

Authors:  Huichun Liang; Ji Xiao; Zhongmei Zhou; Jiao Wu; Fei Ge; Zongcheng Li; Hailin Zhang; Jian Sun; Fubing Li; Rong Liu; Ceshi Chen
Journal:  Oncogene       Date:  2018-01-25       Impact factor: 9.867

6.  miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy.

Authors:  Qian Huang; Jiajia Xia; Lei Wang; Xu Wang; Xiaodong Ma; Qipan Deng; Yong Lu; Munish Kumar; Zhiyuan Zhou; Ling Li; Zhaoyang Zeng; Ken H Young; Qing Yi; Mingzhi Zhang; Yong Li
Journal:  J Hematol Oncol       Date:  2018-04-23       Impact factor: 17.388

7.  MicroRNA-153-3p enhances cell radiosensitivity by targeting BCL2 in human glioma.

Authors:  Deyu Sun; Yi Mu; Haozhe Piao
Journal:  Biol Res       Date:  2018-12-11       Impact factor: 5.612

8.  miR-153 inhibits the migration and the tube formation of endothelial cells by blocking the paracrine of angiopoietin 1 in breast cancer cells.

Authors:  Huichun Liang; Fei Ge; Yuhui Xu; Ji Xiao; Zhongmei Zhou; Rong Liu; Ceshi Chen
Journal:  Angiogenesis       Date:  2018-06-29       Impact factor: 9.596

9.  MicroRNA‑153‑3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways.

Authors:  Long Guo; Yu Bai; Tianyu Ni; Yuan Li; Rong Cao; Shuzhe Ji; Shuzhen Li
Journal:  Int J Oncol       Date:  2021-05-26       Impact factor: 5.650

10.  Mechanism of piR-DQ590027/MIR17HG regulating the permeability of glioma conditioned normal BBB.

Authors:  Xue Leng; Jun Ma; Yunhui Liu; Shuyuan Shen; Hai Yu; Jian Zheng; Xiaobai Liu; Libo Liu; Jiajia Chen; Lini Zhao; Xuelei Ruan; Yixue Xue
Journal:  J Exp Clin Cancer Res       Date:  2018-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.